首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Detection of Complement-Mediated Antibody-Dependent Bactericidal Activity in a Fluorescence-Based Serum Bactericidal Assay for Group B Neisseria meningitidis
【2h】

Detection of Complement-Mediated Antibody-Dependent Bactericidal Activity in a Fluorescence-Based Serum Bactericidal Assay for Group B Neisseria meningitidis

机译:B组脑膜炎奈瑟氏球菌基于荧光的血清杀菌试验中补体介导的抗体依赖性杀菌活性的检测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Serum bactericidal assays (SBAs) for Group B meningococci are considered the methods of choice for the evaluation of functional antimeningococcal antibodies. Many investigators regard SBAs as time- and labor-intensive. Variations in SBA protocols among different laboratories make interpretation of results difficult. Here we describe a fluorescence-based serum bactericidal assay (fSBA) and compare the results obtained with the fSBA to the results obtained with a more conventional SBA. The results generated by both assays were dependent upon the surviving bacteria after incubation, and the assay mixtures contained identical components. Differences between assays lie in how the surviving bacteria are quantified. The fSBA described in the paper uses the fluorescent dye alamarBlue (M. V. Lancaster and R. D. Fields, U.S. patent 5501959, March 1996). The fluorescent signals generated in the fSBA correlate to the oxidative respiration of surviving bacteria. Viable bacteria were detected between 6 and 8 h directly from reaction mixtures in 96-well plates by the fSBA, whereas colonies isolated on semisolid media could be counted after 24 h of incubation. The bactericidal titers generated by both assays were nearly identical. The fSBA described here can be used as an assay for the screening of large quantities of individual sera as complement sources or as a method for the detection of functional antibodies directed against group B Neisseria meningitidis in both human and mouse antisera.
机译:B组脑膜炎球菌的血清杀菌试验(SBA)被认为是评估功能性抗脑膜炎球菌抗体的选择方法。许多研究人员认为SBA既费时又费力。不同实验室之间SBA协议的差异使对结果的解释变得困难。在这里,我们描述了一种基于荧光的血清杀菌试验(fSBA),并将使用fSBA获得的结果与使用更常规的SBA获得的结果进行比较。两种测定产生的结果取决于孵育后存活的细菌,并且测定混合物中包含相同的成分。分析之间的差异在于如何对存活细菌进行定量。该论文中描述的fSBA使用荧光染料alamarBlue(M.V.Lancaster和R.D.Fields,美国专利5501959,1996年3月)。 fSBA中产生的荧光信号与存活细菌的氧化呼吸有关。通过fSBA在96孔板中直接从反应混合物中检测到活菌,时间为6至8小时,而孵育24小时后,可以对半固体培养基上分离出的菌落进行计数。两种测定法产生的杀菌效价几乎相同。此处描述的fSBA可以用作筛选大量个体血清作为补体来源的检测方法,也可以用作检测针对人和小鼠抗血清中B型脑膜炎奈瑟氏球菌的功能性抗体的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号